妊娠合并胎盘绒毛膜血管瘤的围产结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入28项研究共161例产前超声诊断胎盘绒毛膜血管瘤的单胎妊娠,未干预者宫内死亡8.2%、围产期死亡11.1%、早产<37周34.1%,肿瘤增大与不良结局增加相关,胎儿水肿者结局更差,无随机对照试验比较干预与期待治疗。
要点
- 未干预的胎盘绒毛膜血管瘤妊娠宫内死亡8.2%、围产期死亡11.1%、早产<37周34.1%。
- 肿瘤增大与多数不良结局发生率进行性升高相关,胎儿水肿者不良围产结局发生率高。
- 无随机对照试验比较干预与期待治疗在胎儿受损(水肿或高动力循环)征象中的效果。
核心结论
- 胎盘绒毛膜血管瘤与不良围产结局相关,肿块大小和胎儿水肿的存在可能是受影响妊娠围产结局的主要决定因素。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE、CINAHL和ClinicalTrials.gov数据库,纳入28项研究共161例产前超声诊断胎盘绒毛膜血管瘤且无其他相关结构异常的单胎妊娠。
- 采用随机效应模型对比例进行荟萃分析,分别在接受和未接受胎儿治疗的妊娠中评估结局,并按胎儿水肿存在与否及肿瘤大小进行亚组分析。
主要发现
- 未干预的绒毛膜血管瘤妊娠中,宫内死亡发生率为8.2%(95%CI 3.8-15.0%),新生儿死亡为3.8%(95%CI 1.0-8.1%),围产期死亡为11.1%(95%CI 5.0-19.4%)。
- 未干预的绒毛膜血管瘤妊娠中,出生时小于胎龄儿占24.0%(95%CI 13.5-36.5%),早产<37周占34.1%(95%CI 21.1-48.3%),复合新生儿病率占12.0%(95%CI 4.5-22.3%)。
- 超声征象中,胎儿高动力循环征象占21.0%(95%CI 9.6-35.3%),胎儿大脑中动脉收缩期峰值流速增高占20.6%(95%CI 10.9-32.3%)。
- 按肿瘤大小亚组分析(包括接受和未接受干预的妊娠)显示,随着肿瘤增大,多数评估结局的发生率进行性升高。
- 接受宫内治疗的胎儿中,围产期死亡发生率为31.2%(95%CI 18.1-46.1%),57.3%(95%CI 39.2-74.4%)在治疗后水肿或高动力循环消退。
临床怎么用
- 原文未据此给出推荐。
局限性
- 无随机对照试验比较干预与期待治疗在伴有胎儿受损征象(水肿或高动力循环)的绒毛膜血管瘤妊娠中的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the perinatal outcome of singleton pregnancies complicated by placental chorioangioma diagnosed on prenatal ultrasound. METHODS: MEDLINE, EMBASE, CINAHL and ClinicalTrials.gov databases were searched for studies reporting the outcome of pregnancies complicated by placental chorioangioma. Inclusion criteria were singleton pregnancy diagnosed with placental chorioangioma on prenatal ultrasound, with no other associated structural anomaly. The primary outcome was perinatal mortality. Secondary outcomes included associated non-structural anomalies detected on prenatal ultrasound (including fetal hydrops, anemia, polyhydramnios, signs of hyperdynamic circulation and small-for-gestational-age (SGA) fetus), SGA at birth, composite neonatal morbidity and preterm birth. Outcome was assessed separately in pregnancies undergoing and those not undergoing fetal therapy. Subanalyses were performed according to the presence of hydrops and the size of the tumor in all pregnancies diagnosed with chorioangioma. Random-effects meta-analyses of proportions were used to analyze the data. RESULTS: Twenty-eight studies (161 pregnancies) were included. In pregnancies complicated by chorioangioma that did not undergo intervention, intrauterine death occurred in 8.2% (95% CI, 3.8-15.0%), while neonatal death and perinatal death occurred in 3.8% (95% CI, 1.0-8.1%) and 11.1% (95% CI, 5.0-19.4%), respectively. SGA at birth was present in 24.0% (95% CI, 13.5-36.5%) of cases, while preterm birth < 37 weeks complicated 34.1% (95% CI, 21.1-48.3%) of pregnancies. Composite neonatal morbidity occurred in 12.0% (95% CI, 4.5-22.3%) of cases. On ultrasound, signs of fetal hyperdynamic circulation were present in 21.0% (95% CI, 9.6-35.3%) of cases, while peak systolic velocity in the fetal middle cerebral artery was increased in 20.6% (95% CI, 10.9-32.3%). Subanalysis according to the size of chorioangioma, including both pregnancies that did and those that did not undergo intervention, showed a progressive increase in the occurrence of most of the outcomes explored with increasing size of the tumor. Furthermore, the prevalence of adverse perinatal outcome was high in pregnancies complicated by chorioangioma presenting with fetal hydrops. There was no randomized controlled trial comparing intervention vs expectant management in pregnancies complicated by chorioangioma with signs of fetal compromise (hydrops or hyperdynamic circulation). Overall, perinatal mortality occurred in 31.2% (95% CI, 18.1-46.1%) of fetuses undergoing in-utero therapy, and 57.3% (95% CI, 39.2-74.4%) had resolution of hydrops or hyperdynamic circulation after treatment. CONCLUSIONS: Placental chorioangioma is associated with adverse perinatal outcome. The size of the mass and presence of fetal hydrops are likely to be the main determinants of perinatal outcome in affected pregnancies. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Buca D, Iacovella C, Khalil A, et al. Perinatal outcome of pregnancies complicated by placental chorioangioma: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2020. PMID: 31034661. doi:10.1002/uog.20304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。